ライフサイエンスコーパス: mammary artery

1 P<0.05 for both saphenous veins and internal mammary arteries).

2 d as a composite graft based on the internal mammary artery.

3 pressed in human saphenous vein and internal mammary artery.

4 cardiopulmonary bypass with a left internal mammary artery.

5 ceiving BIMA compared with a single internal mammary artery.

6 and survival advantages of the left internal mammary artery.

7 ower patency rates compared to left internal mammary artery.

8 d in segments of saphenous vein and internal mammary artery.

9 ial artery behaves similarly to the internal mammary artery.

10 function and O(2)(.-) generation in internal mammary arteries.

11 and reduced O(2)(.-) generation in internal mammary arteries.

12 In rings of intact internal mammary artery, 1 microM of atrial natriuretic peptide (

13 Among the 796 CABG grafts (345 left internal mammary artery, 12 right internal mammary artery/radial,

14 ter (EC(50)=33+/-7 nmol/L) than the internal mammary artery (203+/-32 nmol/L) or saphenous vein (97+/

15 ter in radial artery (39+/-5%) than internal mammary artery (23+/-6%) or saphenous vein (5+/-2%, both

16 pmol/mg protein) compared with the internal mammary artery (3.5+/-1.3 pmol/mg protein) or saphenous

17 10%) was significantly greater than internal mammary artery (56+/-9%) or saphenous vein (11+/-5%, bot

18 l/mg protein) was also greater than internal mammary artery (6.2+/-0.3 pmol/mg protein) or saphenous

19 nificantly lower than that for left internal mammary arteries (90.3%, P<0.0001) or saphenous vein gra

20 ents with human saphenous veins and internal mammary arteries, adiponectin induced Akt-mediated eNOS

21 eriments with human saphenous veins/internal mammary arteries and adipose tissue, we demonstrated tha

22 Segments of saphenous vein and internal mammary artery and confluent smooth muscle cells culture

23 duit selection, including bilateral internal mammary artery and radial artery use; intraoperative gra

24 Segments of internal mammary artery and saphenous vein from patients undergoi

25 have lower patency rates than left internal mammary artery and saphenous vein grafts.

26 Segments of internal mammary artery and saphenous vein were obtained during c

27 al and patient consent, segments of internal mammary artery and saphenous vein were obtained during c

28 n separate experiments, segments of internal mammary artery and saphenous vein were obtained from fiv

29 Segments of internal mammary artery and saphenous vein were obtained from pat

30 f the radial artery to those of the internal mammary artery and saphenous vein.

31 nary artery bypass grafting with an internal mammary artery and with 1 to 4 vein grafts were recruite

32 we incubated human saphenous veins, internal mammary arteries, and radial arteries (n=6, 8, and 10, r

33 h vessel bed, correlates with contraction in mammary artery, and is modulated by aging.

34 Matched segments of radial artery, internal mammary artery, and saphenous vein (n=24 patients) were

35 hemically in sections of normal human aorta, mammary artery, and saphenous vein.

36 Whereas the use of the left internal mammary artery as a conduit is associated with the highe

37 ls cultured from saphenous vein and internal mammary artery, bacterial lipopolysaccharide triggered t

38 nal mammary artery versus bilateral internal mammary artery (BIMA) conduit in 47 984 index isolated c

39 d that patients receiving bilateral internal mammary artery (BIMA) conduits during coronary artery by

40 ntial survival benefit of bilateral internal mammary artery (BIMA) grafting in comparison with single

41 shown the superiority of bilateral internal mammary artery (BIMA) grafting over single internal mamm

42 90 interaction was detected in human normal mammary arteries but was absent from human atherosclerot

43 asma and in saphenous vein (but not internal mammary artery) but also increased levels of the oxidati

44 Coronary stenting (STENT) and left internal mammary artery bypass grafting of the LAD (LIMA-LAD) are

45 revascularization ranges from left internal mammary artery bypass grafting via sternotomy and minith

46 demonstrate alpha(1a) and alpha(1b)-mediated mammary artery contraction.

47 The superior long-term patency of internal mammary artery coronary bypass grafts compared with veno

48 In human internal mammary arteries, depressed endothelium-dependent relaxa

49 test the effect of permanent right internal mammary artery device closure on coronary collateral fun

50 Permanent right internal mammary artery device closure seems to augment extracard

51 mination 6 weeks after distal right internal mammary artery device closure.

52 d 86.9% of vein graft, and 91.6% of internal mammary artery distal anastomotic sites had <50% stenosi

53 ase for much wider use of bilateral internal mammary arteries during CABG, and off-pump CABG may be b

54 Finally, in human internal mammary artery, endothelial GR is found to be highly nuc

55 The use of bilateral internal thoracic (mammary) arteries for coronary-artery bypass grafting (C

56 rterial conduits, in particular the internal mammary arteries, for coronary bypass surgery whenever p

57 e determined in saphenous veins and internal mammary arteries from 117 patients undergoing CABG.

58 Finally, segments of internal mammary arteries from 26 patients were used in ex vivo e

59 ntified in both saphenous veins and internal mammary arteries from 45 diabetic and 45 matched nondiab

60 idence that patients who receive an internal mammary artery graft (IMA) during coronary artery bypass

61 urgeon effects, and care processes (internal mammary artery graft and perioperative medications use).

62 The left internal mammary artery graft is done by sternal-sparing approach

63 as better for patients receiving an internal mammary artery graft than those receiving vein grafts on

64 ts associated with the durable left internal mammary artery graft to the left anterior descending art

65 arch of associated CAD, wide use of internal mammary artery graft, and vigorous efforts for secondary

66 val attributable to use of the left internal mammary artery graft.

67 Internal mammary artery grafting was adopted slowly and still sho

68 ever, it was similar to that in new internal mammary artery grafts (30.0%).

69 me number of total grafts but fewer internal mammary artery grafts (72% versus 85%, P<0.01), and thos

70 quently, these patients have patent internal mammary artery grafts and require isolated intervention

71 Internal mammary artery grafts were associated with improved outc

72 iabetes, poststernotomy septicemia, internal mammary artery harvest, use of intra-aortic balloon pump

73 anterior thoracotomy using the left internal mammary artery has been performed in some centers with e

74 ibiotic prophylaxis, and use of the internal mammary artery have been advocated as quality indicators

75 It has been established that internal mammary arteries (IMA) are resistant to the development

76 is limited to patients receiving an internal mammary artery (IMA) graft and is apparent earlier in in

77 A single internal mammary artery (IMA) graft has proven survival benefits,

78 The influence of an internal mammary artery (IMA) graft on long-term outcomes after p

79 rcutaneous revascularization of the internal mammary artery (IMA) graft.

80 tive miniCABG cases performed using internal mammary artery (IMA) grafting +/- coronary stenting were

81 sess the pattern of the adoption of internal mammary artery (IMA) grafting in the United States, test

82 dvantages of using routine multiple internal mammary artery (IMA) grafts for coronary artery bypass (

83 of saphenous vein grafts (SVG) and internal mammary artery (IMA) grafts.

84 tery bypass graft surgeries with an internal mammary artery (IMA) have better long-term survival.

85 The internal mammary artery (IMA) is considered the gold-standard con

86 Because the internal mammary artery (IMA) is often visualized during coronary

87 The internal mammary artery (IMA) is the preferred conduit for bypass

88 (DCA) and control samples from the internal mammary artery (IMA) of 7 patients undergoing bypass gra

89 infection in human coronary artery, internal mammary artery (IMA), and saphenous vein (SV).

90 preferable graft, secondary to the internal mammary artery (IMA).

91 Internal mammary arteries (IMAs) and saphenous veins (SVs) were c

92 Segments of internal mammary arteries (IMAs) with their perivascular adipose

93 ethyl ester-inhibitable O(2)(.-) in internal mammary arteries independently of low-density lipoprotei

94 urgical technique by which the left internal mammary artery is anastomosed under direct visualization

95 the combined use of left and right internal mammary arteries (LIMA and RIMA) - collectively known as

96 the course of the translocated left internal mammary artery (LIMA) bypass graft on the surface of the

97 ry (CABG); all received RA and left internal mammary artery (LIMA) grafts.

98 Use of the left internal mammary artery (LIMA) in multivessel coronary artery dis

99 cy of early occlusion when the left internal mammary artery (LIMA) is anastomosed to the left anterio

100 he LAD was performed using the left internal mammary artery (LIMA).

101 issue-specific (atherosclerotic aortic wall, mammary artery, liver, skeletal muscle, and visceral and

102 les with age (<55 versus > or = 65 years) in mammary artery (no change in saphenous vein), accompanie

103 e determined in saphenous veins and internal mammary arteries obtained during surgery.

104 ns and VSMC markers in non-lesioned internal mammary arteries obtained from coronary artery bypass pr

105 n of arginase was determined in the internal mammary artery of patients undergoing bypass surgery.

106 ary artery/SV (n=589) and bilateral internal mammary artery only (n=271) had improved 15-year surviva

107 lly, in tissue segments from either internal mammary artery or saphenous vein, both forskolin and 8-B

108 dial artery is greater than that of internal mammary artery or saphenous vein.

109 II did not contract these arteries, internal mammary arteries, or either type of vein, but it was a p

110 We describe a pedicled internal mammary artery osteomyocutaneous chimeric flap (PIMOC) f

111 33.7%, compared with 4.8% for left internal mammary arteries (P<0.0001), and had a severe stenosis r

112 grafts (P=0.0003) and 4.8% for left internal mammary arteries (P<0.0001).

113 .001]), and patients with bilateral internal mammary artery/radial artery (n=147) and LIMA/radial art

114 t internal mammary artery, 12 right internal mammary artery/radial, and 439 veins), 97 (12%) angiogra

115 ve coronary perfusion plus the left internal mammary artery), reperfusion B (saphenous vein graft per

116 Segments of internal mammary artery responded in a similar manner.

117 , 1.4+/-1.0%, and 3.8+/-0.8% in the internal mammary arteries, saphenous veins, and normal coronary a

118 l subcutaneous resistance arteries, internal mammary arteries, saphenous veins, and small subcutaneou

119 re quantified in saphenous vein and internal mammary artery segments.

120 grafting in comparison with single internal mammary artery (SIMA) grafting has been emphasized by ma

121 artery (BIMA) grafting over single internal mammary artery (SIMA) grafting in select populations.

122 vival than those receiving a single internal mammary artery (SIMA), data on risk of repeat revascular

123 Internal mammary artery specimens were obtained from patients who

124 in perivascular (saphenous vein and internal mammary artery) subcutaneous and mesothoracic adipose ti

125 MultArt subgroups with bilateral internal mammary artery/SV (n=589) and bilateral internal mammary

126 nt survival benefits with bilateral internal mammary arteries, there is no evidence for clinical bene

127 d on experience with using the left internal mammary artery to bypass the left anterior descending co

128 left anterior thoracotomy and left internal mammary artery to LAD grafting without the use of cardio

129 om Phase I in aspirin prescription, internal mammary artery use, and duration of intubation persisted

130 of long-term mortality after single internal mammary artery versus bilateral internal mammary artery

131 The use of internal mammary artery was marginally lower in blacks than in wh

132 The left internal mammary artery was used in 62 patients, and 61 patients

133 of 2.4 grafts was placed, and a new internal mammary artery was used on 47 occasions.

134 The left internal mammary artery was used to preferentially graft the left

135 Samples of saphenous veins and internal mammary arteries were collected from 219 patients with c

136 Side branches of human mammary arteries were implanted into the infrarenal aort

137 s, cultured from saphenous vein and internal mammary artery, were exposed to 20 micrograms/mL of bact